Kiora Pharmaceuticals
KPRX | NASDAQ
$0.98
-$0.25 (-20.33%)
At close: Nov 16, 2026, 4:00 PM ET
$1.00
+$0.02 (+2.04%)
After-hours:
Nov 16, 2026, 7:05 PM ET
-20.33%
(1D)No price chart data available for 1D timeframe.
Rating
25
+7.0 ptsFundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #932/1021 (Top 91%)
Key Statistics
Market Data
Market Cap $6.17M
1D Range
0.93 1.25
52W Range
0.93 2.86
Valuation (TTM)
PE -0.35
PB 0.40
EV/EBITDA 0.87
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $0.00
Cash Flow
FCF Yield -128.0%
SBC Adj. FCF Yield -136.6%
SBC Impact -6.7%
Margins
Gross Margin 90.4%
Operating Margin -1371.7%
FCF Margin -789.8%
Growth (CAGR)
Revenue 3Y | 5Y -132.3% |
142.0%
Dil EPS 3Y | 5Y -202.6% |
85.5%
FCF 3Y | 5Y -247.6% |
10.3%
Returns
ROA -57.0%
ROE -82.1%
ROIC -65.8%
Financial Health
Net Cash
$16.29M
Current Ratio 7.91
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Kiora Pharmaceuticals, Inc., a specialty pharmaceutical firm operating at the clinical stage, is dedicated to the creation and commercialization of treatments for various ophthalmic conditions across ...
Sector Healthcare
Industry Biotechnology
Employees 13
IPO Date Feb 13, 2015
Website www.kiorapharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.28
Beat +26.32%
YoY:
-2900.00% REV
$1M
Beat 0.00%
Next Earnings
Mar 30, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove KPRX